Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Levy, MD
Primus Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sun Valley Arthritis Center
Peoria, Arizona, United States
- Advanced Arthritis Care and Research
Scottsdale, Arizona, United States
- Valerius Medical Group
Los Alamitos, California, United States
- Science and Research Institute, Inc.
Jupiter, Florida, United States
- Jeffrey Alper, Md
Naples, Florida, United States
- Steven Kimmel Md
Tamarac, Florida, United States
- Diagnostic Rheumatology
Indianapolis, Indiana, United States
- Arthritis Treatment Center
Frederick, Maryland, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
- West Virginai Research Institute
Charleston, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2016
- Primary completion
- 31 Jul 2017
- Completion
- 31 Jul 2017
- Last update posted
- 17 Aug 2017
- Registered enrollment
- 87
- Registry id
- NCT02683408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.